Provision of subsidized malaria drugs in shops improves uptake

Reporting the findings of a cluster randomized trial carried out in rural Kenya, Beth Kangwana and colleagues find that provision of packs of the malaria therapy artemether-lumefantrine in shops at a subsidized price more than doubled the proportion of children with fever who received drugs promptly.

Importantly, whilst enabling cheap and easy purchase of in shops enabled treatment of about 44% of children with fever, this is still much lower than the target of treating 80% of children with fever set by the Roll Back Malaria Partnership.

So in addition to this type of pragmatic solution to the problem of access to drugs, additional strategies will be required to boost the numbers of children with who are treated with antimalarials.

More information: Kangwana BP, Kedenge SV, Noor AM, Alegana VA, Nyandigisi AJ, et al. (2011) The Impact of Retail-Sector Delivery of Artemether–Lumefantrine on Malaria Treatment of Children under Five in Kenya: A Cluster Randomized Controlled Trial. PLoS Med 8(5): e1000437. doi:10.1371/journal.pmed.1000437

add to favorites email to friend print save as pdf

Related Stories

Malaria makes relapsing fever more serious

May 08, 2009

Malaria and the Borrelia infection relapsing fever are diseases with similar symptoms that can occur simultaneously. In such cases, the malaria is moderated while the relapsing fever becomes more serious. This is shown in ...

How to treat fevers in African children up for debate

Jan 06, 2009

A new debate in the open access journal PLoS Medicine questions whether all African children with fever should be treated presumptively with antimalarial drugs, or if treatment should wait until laboratory tests confirm malari ...

Supplementary approach to malaria

Feb 05, 2008

Could a simple vitamin A and zinc supplement help protect young children from malaria? A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.

Recommended for you

Supercomputers link proteins to drug side effects

5 hours ago

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

12 hours ago

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments